The role of whole brain radiation therapy in the management of melanoma brain metastases

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Dyer, Michael A ^a   Arvold, Nils D ^b,c   Chen, Yu Hui ^d   Pinnell, Nancy E ^b   Mitin, Timur ^c,e   Lee, Eudocia Q ^b,c   Hodi, F S ^c,d   Ibrahim, Nageatte ^c,d   Weiss, Stephanie E ^f,g   Kelly, Paul J ^h,i   Floyd, Scott R ^c,j   Mahadevan, Anand ^c,j   Alexander, Brian M ^b,c  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f FOX CHASE CANCER CENTER   (United States)

^g TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h University College Cork and INFANT Centre   (Ireland)

ⁱ UNIVERSITY COLLEGE CORK   (Ireland)

^j BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

more..

Author keywords

Brain metastases; Melanoma; Radiosurgery; Whole brain radiation therapy

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CLINICAL EVALUATION; CONTROLLED STUDY; CYBERKNIFE; FEMALE; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; KARNOFSKY PERFORMANCE STATUS; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STEREOTACTIC RADIOSURGERY; TREND STUDY; TUMOR INVASION; UNIVARIATE ANALYSIS; WHOLE BRAIN RADIATION THERAPY; BRAIN NEOPLASMS; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; DISEASE MANAGEMENT; FOLLOW UP; INTENSITY MODULATED RADIATION THERAPY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SECONDARY; SKIN NEOPLASMS; SKULL IRRADIATION; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CRANIAL IRRADIATION; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84902705643     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-143     Document Type: Article

References (29)

1. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005, 75:5-14.
2. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012, 30:419-425.
3. Carlino MS, Fogarty GB, Long GV. Treatment of melanoma brain metastases: a new paradigm. Cancer J 2012, 18:208-212.
4. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751.
5. Weltman E, Salvajoli JV, Brandt RA, de Morais Hanriot R, Prisco FE, Cruz JC, de Oliveira Borges SR, Wajsbrot DB. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 2000, 46:1155-1161.
6. Lorenzoni J, Devriendt D, Massager N, David P, Ruiz S, Vanderlinden B, Van Houtte P, Brotchi J, Levivier M. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 2004, 60:218-224.
7. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008, 70:510-514.
8. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010, 77:655-661.
9. Staudt M, Lasithiotakis K, Leiter U, Meier F, Eigentler T, Bamberg M, Tatagiba M, Brossart P, Garbe C. Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer 2010, 102:1213-1218.
10. Nieder C, Marienhagen K, Geinitz H, Grosu AL. Can current prognostic scores reliably guide treatment decisions in patients with brain metastases from malignant melanoma?. J Cancer Res Ther 2011, 7:47-51.
11. Davies MA, Liu P, McIntyre S, Kim KB, Papadopoulos N, Hwu WJ, Hwu P, Bedikian A. Prognostic factors for survival in melanoma patients with brain metastases. Cancer 2011, 117:1687-1696.
12. Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. Oncologist 2007, 12:884-898.
13. Mori Y, Kondziolka D, Flickinger JC, Kirkwood JM, Agarwala S, Lunsford LD. Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 1998, 42:581-589.
14. Chang EL, Selek U, Hassenbusch SJ, Maor MH, Allen PK, Mahajan A, Sawaya R, Woo SY. Outcome variation among " radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurgery 2005, 56:936-945. discussion 936-945.
15. Yu C, Chen JC, Apuzzo ML, O'Day S, Giannotta SL, Weber JS, Petrovich Z. Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 2002, 52:1277-1287.
16. Selek U, Chang EL, Hassenbusch SJ, Shiu AS, Lang FF, Allen P, Weinberg J, Sawaya R, Maor MH. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys 2004, 59:1097-1106.
17. Brown PD, Brown CA, Pollock BE, Gorman DA, Foote RL. Stereotactic radiosurgery for patients with " radioresistant" brain metastases. Neurosurgery 2002, 51:656-665. discussion 665-657.
18. Buchsbaum JC, Suh JH, Lee SY, Chidel MA, Greskovich JF, Barnett GH. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Cancer 2002, 94:2265-2272.
19. Liew DN, Kano H, Kondziolka D, Mathieu D, Niranjan A, Flickinger JC, Kirkwood JM, Tarhini A, Moschos S, Lunsford LD. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J Neurosurg 2011, 114:769-779.
20. Cranmer LD, Jeter JM, Morgan SS, Hersh EM, Stea B. Whole-brain radiation therapy in melanoma: an open question. Lancet Oncol 2010, 11:13. author reply 13-14.
21. Hara W, Tran P, Li G, Su Z, Puataweepong P, Adler JRJ, Soltys SG, Chang SD, Gibbs IC. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma. Neurosurgery 2009, 64:A26-A32.
22. Manon R, O'Neill A, Knisely J, Werner-Wasik M, Lazarus HM, Wagner H, Gilbert M, Mehta M. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol 2005, 23:8870-8876.
23. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009, 10:1037-1044.
24. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 2011, 29:134-141.
25. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006, 295:2483-2491.
26. Fogarty G, Morton RL, Vardy J, Nowak AK, Mandel C, Forder PM, Hong A, Hruby G, Burmeister B, Shivalingam B, Dhillon H, Thompson JF. Whole brain radiotherapy after local treatment of brain metastases in melanoma patients-a randomised phase III trial. BMC Cancer 2011, 11:142.
27. Samlowski WE, Watson GA, Wang M, Rao G, Klimo PJ, Boucher K, Shrieve DC, Jensen RL. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer 2007, 109:1855-1862.
28. Dyer MA, Kelly PJ, Chen YH, Pinnell NE, Claus EB, Lee EQ, Weiss SE, Arvold ND, Lin NU, Alexander BM. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases. Int J Radiat Oncol Biol Phys 2012, 83:054.
29. Marcus DM, Lowe M, Khan MK, Lawson DH, Crocker IR, Shelton JW, Melton A, Maynard N, Delman KA, Carlson GW, Rizzo M. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma. Am J Clin Oncol 2013, E-pub ahead of print.